Anzeige
Mehr »
Login
Dienstag, 23.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von RTTNews

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoBridgepoint Group Appoints Ruth Prior To Succeed Adam Jones As CFO
DoVistry Commences GBP 100 Mln Share Buyback Programme
DoDiscoverIE On Track To Deliver FY Underlying Earnings Growth In Line With Board's Expectations
DoTransurban Q3 Average Daily Traffic Improves As Workday, Airport Travel Climb
DoLazard, Elaia Partners In Deal To Form French Asset Management Firm Lazard Elaia Capital
DoSantos Q1 Production Down
DoMontrose Environmental Prices Public Offering Of 3 Mln Shares At $37.15/shr
DoServe Robotics Prices Public Offering Of 10 Mln Shares At $4.00/shr
DoIntra-Cellular Therapies Prices Public Offering Of 6.85 Mln Shares At $73.00/shr
MiSynovus Financial Q1 Profit Decreases, misses estimates
MiWintrust Financial Corp. Reveals Increase In Q1 Profit, Beats estimates
MiABVC BioPharma Enters Licensing Agreement With OncoX For Commercialization Of BLEX 404
MiChildren's Place Secures $90 Mln In Unsecured Term Loan From Majority Shareholder Mithaq Capital
MiVanda Pharma Rejects Future Pak's Takeover Proposals; Stock Climbs
MiPrologis Down In Pre-market On Reduced Outlook
MiNRx Pharmaceuticals: New Data Demonstrates No Impact Of NRX-101 On Gut Or Vaginal Flora
MiClearmind Enters Into Licensing Agreement With Yissum Research Development Co.
MiWiSA Technologies Surges 60% In Pre-market
MiBankUnited, Inc. Q1 Profit Declines, but beats estimates
MiBowman Consulting Group Acquires Moore Consulting Engineers Firm
MiNature's Miracle To Acquire Agrify
MiBloom Energy Names Daniel Berenbaum CFO
MiAbbott Laboratories Q1 Earnings Fall, But Ups Annual Earnings Outlook - Update
MiFuture Pak Confirms Offer To Buy Vanda For $7.25 - $7.75 Per Share In Cash; VNDA Up Over 28%
MiSage Therapeutics' Dalzanemdor Phase 2 Study Fails To Meet Primary Endpoint